Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,386 | -31,596 | -23,407 | -9,966 | -2,389 |
| Depreciation Amortization | 758 | 476 | 69 | 127 | 162 |
| Accounts receivable | -170 | 89 | 789 | -897 | 166 |
| Accounts payable and accrued liabilities | -4,726 | -1,059 | 3,869 | 1,597 | -62 |
| Other Working Capital | -4,530 | -933 | 4,769 | 692 | 83 |
| Other Operating Activity | -12,508 | 10,726 | -1,350 | 5,548 | -471 |
| Operating Cash Flow | $-22,562 | $-22,297 | $-15,261 | $-2,899 | $-2,511 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 2,193 | -1,977 |
| PPE Investments | -1,857 | -2,150 | -6,295 | -1,300 | -5 |
| Sale Of Investment | N/A | N/A | N/A | 1,173 | N/A |
| Other Investing Activity | 12 | 67 | 38 | -116 | -50 |
| Investing Cash Flow | $-1,845 | $-2,083 | $-6,257 | $1,950 | $-2,032 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,438 | 22,498 | N/A | N/A |
| Common Stock Issued | 4,652 | 20,387 | N/A | 17,836 | N/A |
| Other Financing Activity | -386 | -169 | 0 | 0 | 0 |
| Financing Cash Flow | $4,266 | $24,656 | $22,498 | $17,836 | $N/A |
| Exchange Rate Effect | 531 | -1,265 | 221 | -828 | -78 |
| Beginning Cash Position | 22,540 | 21,957 | 19,045 | 4,530 | 8,705 |
| End Cash Position | 2,930 | 20,968 | 20,246 | 20,589 | 4,084 |
| Net Cash Flow | $-19,610 | $-989 | $1,201 | $16,059 | $-4,621 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,562 | -22,297 | -15,261 | -2,899 | -2,511 |
| Capital Expenditure | -1,907 | -2,150 | -6,332 | -1,300 | -5 |
| Free Cash Flow | -24,469 | -24,447 | -21,593 | -4,199 | -2,516 |